{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:48:51Z","timestamp":1788608931456,"version":"build-2803163510"},"reference-count":233,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.joim.2020.01.004","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:17:37Z","timestamp":1579202257000},"page":"125-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review"],"prefix":"10.1016","volume":"18","author":[{"given":"Noriko","family":"Shinjyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joim.2020.01.004_b0005","unstructured":"World Health Organization. Global report on diabetes. (2016) [2019-5-31]. https:\/\/www.who.int\/diabetes\/publications\/grd-2016\/en\/."},{"issue":"9833","key":"10.1016\/j.joim.2020.01.004_b0010","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.joim.2020.01.004_b0015","doi-asserted-by":"crossref","DOI":"10.2174\/1573399815666190129155654","article-title":"Pathophysiological mechanisms linking type 2 diabetes and dementia: review of evidence from clinical, translational and epidemiological research","author":"Bello-Chavolla","year":"2019","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"Alzheimer\u2019s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0025","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11064-018-2690-9","article-title":"Diabetes and Alzheimer\u2019s disease: a link not as simple as it seems","volume":"44","author":"Salas","year":"2019","journal-title":"Neurochem Res"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0035","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1998.70052179.x","article-title":"Amyloid \u03b2-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices","volume":"70","author":"Kar","year":"1998","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13543776.2017.1272571","article-title":"Recent advances in acetylcholinesterase inhibitors and reactivators: an update on the patent literature (2012\u20132015)","volume":"27","author":"McHardy","year":"2017","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-016-0136-x","article-title":"Chronic adiponectin deficiency leads to Alzheimer\u2019s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice","volume":"11","author":"Ng","year":"2016","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer\u2019s disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0060","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0065","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b0070","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","article-title":"Type 3 diabetes is sporadic Alzheime\u2019s disease: mini-review","volume":"24","author":"de la Monte","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer\u2019s disease","volume":"10","author":"de la Monte","year":"2006","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.joim.2020.01.004_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrgastro.2012.162","article-title":"Agents that act luminally to treat diarrhea and constipation","volume":"9","author":"Menees","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","article-title":"Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations","volume":"126","author":"Tang","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0095","series-title":"The British flora medica, or, history of the medicinal plants of Great Britain","author":"Castle","year":"1877"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1507\/endocrj.EJ18-0109","article-title":"Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis","volume":"66","author":"Liang","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.joim.2020.01.004_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phymed.2018.09.212","article-title":"Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials","volume":"50","author":"Ju","year":"2018","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b0115","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joim.2020.01.004_b0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fphar.2018.00782","article-title":"The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by berberine","volume":"9","author":"Ma","year":"2018","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0125","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/ptr.6107","article-title":"Berberine: pathways to protect neurons","volume":"32","author":"Lin","year":"2018","journal-title":"Phytother Res"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","article-title":"Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research","volume":"61","author":"Ye","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0135","first-page":"53","article-title":"Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia","volume":"21","author":"Aski","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.joim.2020.01.004_b0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.fct.2017.11.025","article-title":"Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer\u2019s-like disease in rats","volume":"111","author":"Hussien","year":"2018","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b0145","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.joim.2020.01.004_b0150","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/823201","article-title":"Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer\u2019s disease","volume":"2012","author":"Ji","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.joim.2020.01.004_b0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2202-12-125","article-title":"Decrease in the production of \u03b2-amyloid by berberine inhibition of the expression of \u03b2-secretase in HEK293 cells","volume":"12","author":"Zhu","year":"2011","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-2010-100684","article-title":"Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer\u2019s disease inhibit indoleamine 2,3-dioxygenase activity in vitro","volume":"22","author":"Yu","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0165","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1248\/bpb.32.1433","article-title":"Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids","volume":"32","author":"Jung","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.joim.2020.01.004_b0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2202-7-78","article-title":"Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1\u03b2 and inducible nitric oxide synthase in the rat model of Alzheimer\u2019s disease","volume":"7","author":"Zhu","year":"2006","journal-title":"BMC Neurosci"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.pharep.2017.06.006","article-title":"Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-\u03baB signaling, oxidative stress and neuroinflammation","volume":"69","author":"He","year":"2017","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0180","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.3390\/molecules22060925","article-title":"Phytochemical quantification and the in vitro acetylcholinesterase inhibitory activity of Phellodendron chinense and its components","volume":"22","author":"Kim","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0185","first-page":"594","article-title":"Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells","volume":"20","author":"Sadeghnia","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.joim.2020.01.004_b0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exger.2017.02.004","article-title":"Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of \u03b2-amyloid in APP\/tau\/PS1 mouse model of Alzheimer\u2019s disease","volume":"91","author":"Huang","year":"2017","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0195","article-title":"Berberine attenuates axonal transport impairment and axonopathy induced by calyculin A in N2a cells","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.joim.2020.01.004_b0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2013.12.006","article-title":"Berberine rescues D-galactose-induced synaptic\/memory impairment by regulating the levels of Arc","volume":"117","author":"Zhan","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b0205","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/jphp.12172","article-title":"Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer\u2019s disease and antioxidant activity","volume":"65","author":"Bonesi","year":"2013","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0210","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.2042-7158.2012.01529.x","article-title":"Berberine suppresses amyloid-\u03b2-induced inflammatory response in microglia by inhibiting nuclear factor-\u03baB and mitogen-activated protein kinase signaling pathways","volume":"64","author":"Jia","year":"2012","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0215","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13880209.2013.839714","article-title":"Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide","volume":"52","author":"Chatuphonprasert","year":"2014","journal-title":"Pharm Biol"},{"key":"10.1016\/j.joim.2020.01.004_b0220","article-title":"Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats","author":"Yin","year":"2018","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2011.01.022","article-title":"Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes","volume":"220","author":"Bhutada","year":"2011","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcb.22580","article-title":"Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia","volume":"110","author":"Lu","year":"2010","journal-title":"J Cell Biochem"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.taap.2013.08.008","article-title":"Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth","volume":"272","author":"Hsu","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00213-018-5090-6","article-title":"Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to intracerebroventricular injection of streptozotocin","volume":"236","author":"de Oliveira","year":"2019","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0245","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/rej.2017.1972","article-title":"Berberine improves diabetic encephalopathy through the SIRT1\/ER stress pathway in db\/db mice","volume":"21","author":"Li","year":"2018","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.joim.2020.01.004_b0250","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.biopha.2017.07.142","article-title":"Influence of quercetin, naringenin and berberine on glucose transporters and insulin signaling molecules in brain of streptozotocin-induced diabetic rats","volume":"94","author":"Sandeep","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2020.01.004_b0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fphar.2017.00334","article-title":"Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats","volume":"8","author":"Chen","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuro.2016.10.008","article-title":"Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer\u2019s-like dementia: involvement of acetylcholinesterase and cell death","volume":"57","author":"de Oliveira","year":"2016","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0265","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12035-013-8559-7","article-title":"Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats","volume":"49","author":"Moghaddam","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11011-013-9411-5","article-title":"Berberine chloride improved synaptic plasticity in STZ induced diabetic rats","volume":"28","author":"Moghaddam","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"1\u20133","key":"10.1016\/j.joim.2020.01.004_b0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejphar.2012.10.020","article-title":"Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats","volume":"698","author":"Kalalian-Moghaddam","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0280","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.3892\/mmr.2017.7467","article-title":"Protective role of berberine and Coptis chinensis extract on T2MD rats and associated islet Rin-5f cells","volume":"16","author":"Jiang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103702","article-title":"Berberine promotes glucose consumption independently of AMP-activated protein kinase activation","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0290","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ptr.5587","article-title":"Metabolomics study of type 2 diabetes mellitus and the antidiabetic effect of berberine in Zucker diabetic fatty rats using uplc-ESI-hdms","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2020.01.004_b0295","article-title":"Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.joim.2020.01.004_b0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/jrms.JRMS_1078_17","article-title":"Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients","volume":"23","author":"Memon","year":"2018","journal-title":"J Res Med Sci"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jmf.2012.2648","article-title":"Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy","volume":"16","author":"Kim","year":"2013","journal-title":"J Med Food"},{"key":"10.1016\/j.joim.2020.01.004_b0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2016.02.007","article-title":"Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats","volume":"774","author":"Zhou","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0315","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2017.12.029","article-title":"Adenosine monophosphate-activated protein kinase modulation by berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic neuropathy","volume":"131","author":"Yerra","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.joim.2020.01.004_b0320","first-page":"2092","article-title":"Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine","volume":"19","author":"Tian","year":"2013","journal-title":"Mol Vis"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b0325","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1167\/iovs.16-19291","article-title":"Beneficial effects of berberine on oxidized LDL-induced cytotoxicity to human retinal M\u00fcller cells","volume":"57","author":"Fu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joim.2020.01.004_b0330","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.biopha.2018.09.140","article-title":"Berberine attenuates apoptosis in rat retinal M\u00fcller cells stimulated with high glucose via enhancing autophagy and the AMPK\/mTOR signaling","volume":"108","author":"Chen","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0335","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.talanta.2010.01.015","article-title":"Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics","volume":"81","author":"Gu","year":"2010","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0340","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00210-010-0502-0","article-title":"Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study","volume":"381","author":"Liu","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0345","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jep.2012.05.022","article-title":"Berberine acutely inhibits the digestion of maltose in the intestine","volume":"142","author":"Li","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0350","article-title":"Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0355","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-13-0184","article-title":"Alteration of the intestinal barrier and GLP2 secretion in berberine-treated type 2 diabetic rats","volume":"218","author":"Shan","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.joim.2020.01.004_b0360","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1472-6882-14-188","article-title":"Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.joim.2020.01.004_b0365","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.joim.2020.01.004_b0370","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2017.11.023","article-title":"Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe-\/- mice","volume":"268","author":"Zhu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0375","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41387-018-0061-x","article-title":"Restoration of GLP-1 secretion by berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice","volume":"8","author":"Sun","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"1\u20133","key":"10.1016\/j.joim.2020.01.004_b0380","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2010.04.033","article-title":"Effects of berberine on matrix accumulation and NF-\u03baB signal pathway in alloxan-induced diabetic mice with renal injury","volume":"638","author":"Liu","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.abb.2010.07.012","article-title":"Berberine ameliorates renal injury in diabetic C57BL\/6 mice: involvement of suppression of SphK-S1P signaling pathway","volume":"502","author":"Lan","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0390","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.metabol.2010.02.005","article-title":"Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats","volume":"60","author":"Wang","year":"2011","journal-title":"Metabolism"},{"issue":"8\u20139","key":"10.1016\/j.joim.2020.01.004_b0395","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.phymed.2012.03.003","article-title":"Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin","volume":"19","author":"Wu","year":"2012","journal-title":"Phytomedicine"},{"issue":"1\u20133","key":"10.1016\/j.joim.2020.01.004_b0400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2012.10.003","article-title":"Berberine suppresses high glucose-induced TGF-\u03b21 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1\/AP-1 pathway","volume":"697","author":"Lan","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043874","article-title":"Berberine reduces fibronectin expression by suppressing the S1P\u2013S1P2 receptor pathway in experimental diabetic nephropathy models","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0410","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s11033-012-2321-5","article-title":"Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats","volume":"40","author":"Wang","year":"2013","journal-title":"Mol Biol Rep"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0415","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1007\/s11033-014-3196-4","article-title":"Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy","volume":"41","author":"Tang","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"1\u20132","key":"10.1016\/j.joim.2020.01.004_b0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2014.01.022","article-title":"Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-\u03baB\/AP-1 pathways","volume":"384","author":"Lan","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0425","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10799893.2014.917324","article-title":"The renoprotective effects of berberine via the EP4-G\u03b1s-cAMP signaling pathway in different stages of diabetes in rats","volume":"34","author":"Yang","year":"2014","journal-title":"J Recept Signal Transduct Res"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0430","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/1440-1681.12402","article-title":"Renoprotective effect of berberine on type 2 diabetic nephropathy in rats","volume":"42","author":"Sun","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.joim.2020.01.004_b0435","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejphar.2015.07.040","article-title":"Renoprotective effects of berberine through regulation of the MMPs\/TIMPs system in streptozocin-induced diabetic nephropathy in rats","volume":"764","author":"Ni","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0440","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/1753-0407.12349","article-title":"Renoprotective effects of berberine and its potential effect on the expression of \u03b2-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats","volume":"8","author":"Tang","year":"2016","journal-title":"J Diabetes"},{"issue":"11","key":"10.1016\/j.joim.2020.01.004_b0445","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.metabol.2010.03.009","article-title":"Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles","volume":"59","author":"Ma","year":"2010","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0450","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jcmm.12837","article-title":"Renoprotective effect of berberine via regulating the PGE2-EP1-G\u03b1q-Ca2+ signaling pathway in glomerular mesangial cells of diabetic rats","volume":"20","author":"Ni","year":"2016","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0455","doi-asserted-by":"crossref","first-page":"E1327","DOI":"10.3390\/ijms17081327","article-title":"Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice","volume":"17","author":"Zhang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joim.2020.01.004_b0460","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","article-title":"Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes","volume":"794","author":"Jin","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0465","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3892\/mmr.2017.6707","article-title":"Protective effect of berberine on renal fibrosis caused by diabetic nephropathy","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.joim.2020.01.004_b0470","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2018.01.034","article-title":"Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGF\u03b21-PI3K\/AKT pathway","volume":"824","author":"Wang","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0475","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.K10E-043","article-title":"Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR\u03b1 and PPAR\u03b1 transcriptional programs","volume":"57","author":"Liu","year":"2010","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40659-018-0157-8","article-title":"Berberine ameliorates diabetic nephropathy by inhibiting TLR4\/NF-\u03baB pathway","volume":"51","author":"Zhu","year":"2018","journal-title":"Biol Res"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0485","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fitote.2010.08.019","article-title":"Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver","volume":"82","author":"Zhou","year":"2011","journal-title":"Fitoterapia"},{"issue":"9","key":"10.1016\/j.joim.2020.01.004_b0490","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1507\/endocrj.K11E-024","article-title":"Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL\/6 mice through activation of Akt signaling pathway","volume":"58","author":"Xie","year":"2011","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0495","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3109\/13880209.2012.655377","article-title":"Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine","volume":"50","author":"Lao-ong","year":"2012","journal-title":"Pharm Biol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0500","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2010.05.153","article-title":"Berberine inhibits PTP1B activity and mimics insulin action","volume":"397","author":"Chen","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0505","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.mito.2013.09.002","article-title":"Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation","volume":"13","author":"Teodoro","year":"2013","journal-title":"Mitochondrion"},{"issue":"25","key":"10.1016\/j.joim.2020.01.004_b0510","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.3748\/wjg.v21.i25.7777","article-title":"Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats","volume":"21","author":"Jiang","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0515","first-page":"7535","article-title":"Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11596-016-1543-5","article-title":"Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells","volume":"36","author":"Li","year":"2016","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152097","article-title":"Berberine attenuates development of the hepatic gluconeogenesis and lipid metabolism disorder in type 2 diabetic mice and in palmitate-incubated HepG2 cells through suppression of the HNF-4\u03b1 miR122 pathway","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0530","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bph.14079","article-title":"Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21","volume":"175","author":"Sun","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0535","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biopha.2018.01.007","article-title":"Effects of berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats","volume":"99","author":"Chandirasegaran","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0540","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0043-125066","article-title":"Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway","volume":"126","author":"Liu","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0545","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12020-018-1689-y","article-title":"Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3","volume":"62","author":"Zhang","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ptr.3097","article-title":"Berberine elicits anti-arrhythmic effects via IK1\/Kir2.1 in the rat type 2 diabetic myocardial infarction model","volume":"25","author":"Wang","year":"2011","journal-title":"Phytother Res"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b0555","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biochi.2011.04.013","article-title":"Berberine acutely activates the glucose transport activity of GLUT1","volume":"93","author":"Cok","year":"2011","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0560","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1248\/bpb.34.644","article-title":"Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters","volume":"34","author":"Li","year":"2011","journal-title":"Biol Pharm Bull"},{"issue":"3\u20134","key":"10.1016\/j.joim.2020.01.004_b0565","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.phymed.2011.11.002","article-title":"Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats","volume":"19","author":"Wang","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2020.01.004_b0570","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/260464","article-title":"Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4","volume":"2013","author":"Zhang","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.joim.2020.01.004_b0575","article-title":"Effect of berberine on PPAR\u03b1\/NO activation in high glucose- and insulin-induced cardiomyocyte hypertrophy","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid Based Complement Altern Med"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0580","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10495-014-0977-0","article-title":"Berberine reduces ischemia\/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats","volume":"19","author":"Chen","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.joim.2020.01.004_b0585","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fitote.2014.08.006","article-title":"Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C\/EBP-\u03b1 and PPAR-\u03b3","volume":"98","author":"Choi","year":"2014","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125667","article-title":"Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0595","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbalip.2015.12.017","article-title":"Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes","volume":"1861","author":"Chang","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0600","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1074248415627873","article-title":"Berberine pretreatment confers cardioprotection against ischemia-reperfusion injury in a rat model of type 2 diabetes","volume":"21","author":"Chang","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0605","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/bph.13466","article-title":"Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signaling in diabetic rats","volume":"173","author":"Geng","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0610","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.intimp.2012.01.003","article-title":"Protective effect of berberine on serum glucose levels in non-obese diabetic mice","volume":"12","author":"Chueh","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0615","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12933-016-0382-9","article-title":"Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca2+ handling in smooth muscle cells","volume":"15","author":"Ma","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0620","first-page":"FF13","article-title":"Myocardial salvaging effects of berberine in experimental diabetes co-existing with myocardial infarction","volume":"10","author":"Suman","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b0625","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/jdi.12516","article-title":"Berberine activates peroxisome proliferator-activated receptor \u03b3 to increase atherosclerotic plaque stability in Apoe-\/- mice with hyperhomocysteinemia","volume":"7","author":"Li","year":"2016","journal-title":"J Diabetes Investig"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0630","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-17-0014","article-title":"Berberine reduced blood pressure and improved vasodilation in diabetic rats","volume":"59","author":"Ma","year":"2017","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"10.1016\/j.joim.2020.01.004_b0635","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11745-017-4300-z","article-title":"Berberine inhibits oxygen consumption rate independent of alteration in cardiolipin levels in H9c2 cells","volume":"52","author":"Chang","year":"2017","journal-title":"Lipids"},{"key":"10.1016\/j.joim.2020.01.004_b0640","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biopha.2018.05.110","article-title":"Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice","volume":"105","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0645","doi-asserted-by":"crossref","first-page":"H802","DOI":"10.1152\/ajpheart.00093.2018","article-title":"Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2\/MMP-9 expression in diabetic rats","volume":"315","author":"Li","year":"2018","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"10.1016\/j.joim.2020.01.004_b0650","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.biopha.2018.08.148","article-title":"Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-\/- mice","volume":"107","author":"Shi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2020.01.004_b0655","doi-asserted-by":"crossref","first-page":"4395137","DOI":"10.1155\/2018\/4395137","article-title":"The role of berberine in the prevention of HIF-1\u03b1 activation to alleviate adipose tissue fibrosis in high-fat-diet-induced obese mice","volume":"2018","author":"Hu","year":"2018","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.joim.2020.01.004_b0660","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3389\/fphar.2018.01121","article-title":"Berberine ameliorates high glucose-induced cardiomyocyte injury via AMPK signaling activation to stimulate mitochondrial biogenesis and restore autophagic flux","volume":"9","author":"Hang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0665","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/519371","article-title":"Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance","volume":"2011","author":"Chen","year":"2011","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.joim.2020.01.004_b0670","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2018.10.453","article-title":"Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity","volume":"130","author":"Paul","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0675","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ptr.6217","article-title":"Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-\u03baB and AMPK signaling pathways","volume":"33","author":"Pei","year":"2019","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2020.01.004_b0680","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2019.04.017","article-title":"Berberine stimulates fibroblast growth factor 21 by modulating the molecular clock component brain and muscle Arnt-like 1 in brown adipose tissue","volume":"164","author":"Hirai","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"10.1016\/j.joim.2020.01.004_b0685","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/jf201627w","article-title":"Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice","volume":"59","author":"Chueh","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0690","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.foodchem.2011.10.065","article-title":"Berberine, an isoquinoline alkaloid, inhibits streptozotocin-induced apoptosis in mouse pancreatic islets through down-regulating Bax\/Bcl-2 gene expression ratio","volume":"132","author":"Chueh","year":"2012","journal-title":"Food Chem"},{"issue":"1\u20133","key":"10.1016\/j.joim.2020.01.004_b0695","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2012.07.052","article-title":"Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic \u03b2-cell","volume":"694","author":"Shen","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopha.2017.08.040","article-title":"Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of streptozotocin induced diabetic rats","volume":"95","author":"Chandirasegaran","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b0705","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1002\/jcb.26089","article-title":"Berberine alleviates oxidative stress in islets of diabetic mice by inhibiting miR-106b expression and up-regulating SIRT1","volume":"118","author":"Chen","year":"2017","journal-title":"J Cell Biochem"},{"issue":"13","key":"10.1016\/j.joim.2020.01.004_b0710","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1111\/bph.12666","article-title":"Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets","volume":"171","author":"Liu","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joim.2020.01.004_b0715","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fitote.2014.01.008","article-title":"Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes","volume":"93","author":"Yang","year":"2014","journal-title":"Fitoterapia"},{"issue":"1\u20132","key":"10.1016\/j.joim.2020.01.004_b0720","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2013.07.019","article-title":"Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA\/ROCK signaling","volume":"381","author":"Xie","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.joim.2020.01.004_b0725","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exger.2017.10.029","article-title":"Role of D-galactose-induced brain aging and its potential used for therapeutic interventions","volume":"101","author":"Shwe","year":"2018","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0730","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-140414","article-title":"The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"43","author":"Yu","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0735","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14728222.2018.1524877","article-title":"Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer\u2019s disease","volume":"22","author":"Sharma","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.joim.2020.01.004_b0740","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.joim.2020.01.004_b0745","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2019.00187","article-title":"Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function","volume":"10","author":"Kitada","year":"2019","journal-title":"Front Endocrinol"},{"issue":"18","key":"10.1016\/j.joim.2020.01.004_b0750","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/ars.2014.6221","article-title":"NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease","volume":"23","author":"Vendrov","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0755","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0760","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2006.09.026","article-title":"Age-related changes in glycogen synthase kinase 3\u03b2 (GSK3\u03b2) immunoreactivity in the central nervous system of rats","volume":"409","author":"Lee","year":"2006","journal-title":"Neurosci Lett"},{"issue":"5719","key":"10.1016\/j.joim.2020.01.004_b0765","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1110301","article-title":"Cell biology. GSK3\u03b2 and microtubule assembly in axons","volume":"308","author":"Zhou","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0770","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/neu.2007.0369","article-title":"Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K\/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury","volume":"25","author":"Wu","year":"2008","journal-title":"J Neurotrauma"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064460","article-title":"Molecular mechanisms of environmental enrichment: impairments in Akt\/GSK3\u03b2, neurotrophin-3 and CREB signaling","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0780","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/gbb.12283","article-title":"GSK3\u03b2 isoform-selective regulation of depression, memory and hippocampal cell proliferation","volume":"15","author":"Pardo","year":"2016","journal-title":"Genes Brain Behav"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0785","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.biopsych.2009.04.015","article-title":"Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3\u03b1\/\u03b2 impairs in vivo neural precursor cell proliferation","volume":"66","author":"Eom","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0790","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/alzrt265","article-title":"Dietary regulation of PI3K\/AKT\/GSK3\u03b2 pathway in Alzheimer\u2019s disease","volume":"6","author":"Kitagishi","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0795","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: a review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res Rev"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0805","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0124","article-title":"Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer\u2019s disease","volume":"2","author":"Haan","year":"2006","journal-title":"Nat Clin Pr Neurol"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0815","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/bcb-2014-0107","article-title":"Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies","volume":"93","author":"Chang","year":"2015","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0820","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4239\/wjd.v10.i3.169","article-title":"Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron","volume":"10","author":"Xourgia","year":"2019","journal-title":"World J Diabetes"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0825","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"10.1016\/j.joim.2020.01.004_b0830","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1042\/CS20160382","article-title":"Hypercholesterolaemia and vascular dementia","volume":"131","author":"Appleton","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"10004","key":"10.1016\/j.joim.2020.01.004_b0835","first-page":"698","article-title":"Vascular dementia","volume":"386","author":"O\u2019Brien","year":"2015","journal-title":"Lancet"},{"issue":"6944","key":"10.1016\/j.joim.2020.01.004_b0840","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/bmj.308.6944.1604","article-title":"Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study","volume":"308","author":"Breteler","year":"1994","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/j.joim.2020.01.004_b0845","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000080027","article-title":"Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia","volume":"18","author":"Polidori","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.joim.2020.01.004_b0850","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0855","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13300-016-0167-x","article-title":"Diabetes dyslipidemia","volume":"7","author":"Schofield","year":"2016","journal-title":"Diabetes Ther"},{"issue":"9733","key":"10.1016\/j.joim.2020.01.004_b0860","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0865","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-1680","article-title":"Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study","volume":"98","author":"Abbasi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0870","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17512433.2019.1567328","article-title":"Future perspectives of the pharmacological management of diabetic dyslipidemia","volume":"12","author":"Patti","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9435","key":"10.1016\/j.joim.2020.01.004_b0875","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0880","doi-asserted-by":"crossref","first-page":"E2968","DOI":"10.3390\/ijms19102968","article-title":"The main determinants of diabetes mellitus vascular complications: endothelial dysfunction and platelet hyperaggregation","volume":"19","author":"Carrizzo","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0885","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/157016112798829797","article-title":"Diabetes mellitus and vascular endothelial dysfunction: current perspectives","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0890","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccl.2004.06.009","article-title":"Platelet function, coagulopathy, and impaired fibrinolysis in diabetes","volume":"22","author":"Sobel","year":"2004","journal-title":"Cardiol Clin"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0895","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diabet.2018.07.003","article-title":"Diabetes-related cardiomyopathy: the sweet story of glucose overload from epidemiology to cellular pathways","volume":"45","author":"Joubert","year":"2019","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0900","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.joim.2020.01.004_b0905","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fphys.2018.00070","article-title":"PVAT and its relation to brown, beige, and white adipose tissue in development and function","volume":"9","author":"Hildebrand","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.joim.2020.01.004_b0910","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diabres.2018.08.011","article-title":"Non-alcoholic fatty liver disease: relationship with cardiovascular risk markers and clinical endpoints","volume":"144","author":"Buckley","year":"2018","journal-title":"Diabetes Res Clin Pr"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0920","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults","volume":"40","author":"Chen","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b0925","first-page":"1049","article-title":"Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis","volume":"10","author":"de la Monte","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0930","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-2009-0983","article-title":"Mechanisms of ceramide-mediated neurodegeneration","volume":"16","author":"Tong","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0935","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-2009-0984","article-title":"Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis","volume":"16","author":"Lyn-Cook","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.joim.2020.01.004_b0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","article-title":"Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model","volume":"13","author":"Kim","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b0945","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","article-title":"Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies","volume":"88","author":"Deckers","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.joim.2020.01.004_b0950","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000346722","article-title":"Kidney disease and cognitive function","volume":"179","author":"Elias","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b0955","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023520","article-title":"How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK","volume":"8","author":"Hobson","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0960","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.336","article-title":"Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies","volume":"79","author":"Kurella Tamura","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b0965","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/WAD.0000000000000178","article-title":"Cognitive impairment and dementia in older adults with chronic kidney disease: a review","volume":"30","author":"Zammit","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0970","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jfma.2019.01.011","article-title":"Cognitive impairment in patients with end-stage renal disease: accelerated brain aging?","volume":"118","author":"Chiu","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b0975","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/boc.201800077","article-title":"AMPK signaling: implications for podocyte biology in diabetic nephropathy","volume":"111","author":"Szrejder","year":"2019","journal-title":"Biol Cell"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b0980","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.3390\/cells8010061","article-title":"Autophagy in chronic kidney diseases","volume":"8","author":"Lin","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b0985","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.ajpath.2015.04.014","article-title":"Activation of AMP-activated protein kinase prevents TGF-\u03b21-induced epithelial-mesenchymal transition and myofibroblast activation","volume":"185","author":"Thakur","year":"2015","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b0990","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.joim.2020.01.004_b0995","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fendo.2019.00029","article-title":"Impact of gut microbiota on host glycemic control","volume":"10","author":"G\u00e9rard","year":"2019","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b1000","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11892-018-1020-6","article-title":"The gut microbiome as a target for the treatment of type 2 diabetes","volume":"18","author":"Aydin","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b1005","first-page":"E32","article-title":"The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into \u201cOld\u201d diseases","volume":"6","author":"Harsch","year":"2018","journal-title":"Med Sci"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b1010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11892-018-1057-6","article-title":"Altered gut microbiota in type 2 diabetes: just a coincidence?","volume":"18","author":"Sircana","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.joim.2020.01.004_b1015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jnutbio.2018.10.003","article-title":"Gut microbiome and type 2 diabetes: where we are and where to go?","volume":"63","author":"Sharma","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.joim.2020.01.004_b1020","doi-asserted-by":"crossref","first-page":"2037838","DOI":"10.1155\/2018\/2037838","article-title":"Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases","volume":"2018","author":"Beliz\u00e1rio","year":"2018","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b1025","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b1030","first-page":"178","article-title":"Gut microbiota: a new protagonist in the risk of cardiovascular disease?","volume":"31","author":"Garc\u00eda-R\u00edos","year":"2019","journal-title":"Clin Investig Arter"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b1035","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.3390\/diseases7010021","article-title":"Impact of gut dysbiosis on neurohormonal pathways in chronic kidney disease","volume":"7","author":"Jazani","year":"2019","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b1040","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer\u2019s disease\u2014a critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b1045","first-page":"401","article-title":"Effects of traditional Chinese medicine on intestinal bacteria: a review","volume":"11","author":"Chen","year":"2012","journal-title":"Indian J Trad Knowl"},{"issue":"7","key":"10.1016\/j.joim.2020.01.004_b1050","doi-asserted-by":"crossref","first-page":"RA164","DOI":"10.12659\/MSM.881842","article-title":"Modulating gut microbiota as an anti-diabetic mechanism of berberine","volume":"17","author":"Han","year":"2011","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b1055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/WCO.0000000000000645","article-title":"Potential retinal biomarkers for dementia: what is new?","volume":"32","author":"Cheung","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b1060","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db07-1552","article-title":"Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action","volume":"57","author":"Turner","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.joim.2020.01.004_b1065","doi-asserted-by":"crossref","first-page":"E3092","DOI":"10.3390\/ijms19103092","article-title":"Nutritional modulation of AMPK-impact upon metabolic-inflammation","volume":"19","author":"Lyons","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.joim.2020.01.004_b1070","first-page":"3322","article-title":"Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation","volume":"10","author":"Hu","year":"2018","journal-title":"Am J Transl Res"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b1075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","article-title":"Diabetes mellitus and dementia","volume":"14","author":"Ninomiya","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b1080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b1085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11910-019-0973-4","article-title":"Diabetes therapies for dementia","volume":"19","author":"Moran","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b1090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12906-019-2510-z","article-title":"Neuroprotective effects of berberine in animal models of Alzheimer\u2019s disease: a systematic review of pre-clinical studies","volume":"19","author":"Yuan","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"10.1016\/j.joim.2020.01.004_b1095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11427-015-4829-0","article-title":"Therapeutic potential of berberine against neurodegenerative diseases","volume":"58","author":"Jiang","year":"2015","journal-title":"Sci China Life Sci"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b1100","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/molecules16086732","article-title":"Berberine: a potential multipotent natural product to combat Alzheimer\u2019s disease","volume":"16","author":"Ji","year":"2011","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b1105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ptr.2968","article-title":"Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders","volume":"24","author":"Kulkarni","year":"2010","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.joim.2020.01.004_b1110","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jssc.201500063","article-title":"Quantitative determination of isoquinoline alkaloids and chlorogenic acid in Berberis species using ultra high performance liquid chromatography with hybrid triple quadrupole linear ion trap mass spectrometry","volume":"38","author":"Singh","year":"2015","journal-title":"J Sep Sci"},{"issue":"2","key":"10.1016\/j.joim.2020.01.004_b1115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpha.2016.10.002","article-title":"Analysis of isoquinoline alkaloids from mahonia leschenaultia and mahonia napaulensis roots using UHPLC-Orbitrap-MSn and UHPLC-QqQLIT-MS\/MS","volume":"7","author":"Singh","year":"2017","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.joim.2020.01.004_b1120","doi-asserted-by":"crossref","first-page":"9369872","DOI":"10.1155\/2017\/9369872","article-title":"UPLC-MS\/MS profile of alkaloids with cytotoxic properties of selected medicinal plants of the Berberidaceae and Papaveraceae families","volume":"2017","author":"Och","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.joim.2020.01.004_b1125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jpba.2018.09.012","volume":"161","author":"Qi","year":"2018","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.joim.2020.01.004_b1130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jchromb.2011.11.026","article-title":"Analysis of goldenseal, Hydrastis canadensis L., and related alkaloids in urine using HPLC with UV detection","volume":"880","author":"Dawes","year":"2012","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"11","key":"10.1016\/j.joim.2020.01.004_b1135","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/np049868j","article-title":"A new glucosyl feruloyl quinic acid as a potential marker for roots and rhizomes of goldenseal, Hydrastis canadensis","volume":"67","author":"McNamara","year":"2004","journal-title":"J Nat Prod"},{"issue":"13","key":"10.1016\/j.joim.2020.01.004_b1140","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jssc.201400012","article-title":"Identification and analysis of alkaloids in cortex Phellodendron amurense by high-performance liquid chromatography with electrospray ionization mass spectrometry coupled with photodiode array detection","volume":"37","author":"Xian","year":"2014","journal-title":"J Sep Sci"},{"issue":"4","key":"10.1016\/j.joim.2020.01.004_b1145","first-page":"451","article-title":"Kalo\u0111era Z. Chemical differentiation of Berberis croatica and B. vulgaris using HPLC fingerprinting","volume":"83","author":"Kon\u010di\u0107","year":"2010","journal-title":"Croat Chem Acta"},{"key":"10.1016\/j.joim.2020.01.004_b1150","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2147\/DDDT.S171025","article-title":"The total alkaloids from Coptis chinensis Franch improve cognitive deficits in type 2 diabetic rats","volume":"12","author":"Li","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.joim.2020.01.004_b1155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0031-1280377","article-title":"Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors","volume":"78","author":"Steinmann","year":"2012","journal-title":"Planta Med"},{"issue":"8","key":"10.1016\/j.joim.2020.01.004_b1160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.joim.2020.01.004_b1165","first-page":"557","article-title":"A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome","volume":"20","author":"Tabeshpour","year":"2017","journal-title":"Iran J Basic Med Sci"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496420300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496420300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:49:51Z","timestamp":1761864591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496420300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":233,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2095496420300054"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2020.01.004","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2020.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}